The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
New medicines to improve control and contribute to the eradication of malaria
Abstract
Despite being one of the most prevalent tropical diseases, for many years malaria was not a commercial priority for the pharmaceutical industry. However, in response to the emergence and spread of resistance to the available antimalarial drugs, there has been a renaissance in the discovery and development of new medicines to control the disease in the last few years. The persistent threat of resistance means that new molecules with novel mechanisms of action are continually required. Furthermore, the recent call for the elimination and eradication of malaria has prompted an extension of the stages of the life cycle of malaria parasites that should be targeted by new molecules. Recent advances in genome-based technologies and in in vitro screening of whole parasites have broadened the range of therapeutic targets and are accelerating the development of a new generation of treatments for both malaria control and eradication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D., & Fukuda, M. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0805011 · Cited by 1,785
The economic burden of malaria
Gallup, J., & Sachs, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.85 · Cited by 1,480
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Plasmodium knowlesi Malaria in Humans Is Widely Distributed and Potentially Life Threatening
Cox-Singh, J., Davis, T. M. E., Lee, K.-S., Shamsul, S. S. G., Matusop, A., Ratnam, S., Rahman, H. A., Conway, D. J., & Singh, B. (2008) · Clinical Infectious Diseases · doi:10.1086/524888 · Cited by 886
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Comparative genomics of the neglected human malaria parasite Plasmodium vivax
Carlton, J. M., Adams, J. H., Silva, J. C., Bidwell, S. L., Lorenzi, H., Caler, E., Crabtree, J., Angiuoli, S. V., Merino, E. F., Amedeo, P., et al. (2008) · Nature · doi:10.1038/nature07327 · Cited by 835
Malaria : parasite biology, pathogenesis, and protection
Sherman, I. W. (1998) · ASM Press eBooks · Cited by 760
Artemisinin: mechanisms of action, resistance and toxicity
Meshnick, S. R. (2002) · International Journal for Parasitology · doi:10.1016/s0020-7519(02)00194-7 · Cited by 720
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy
Meshnick, S. R., Taylor, T. E., & Kamchonwongpaisan, S. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.2.301-315.1996 · Cited by 710
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Antimalarial drug resistance and combination chemotherapy
White, N. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0426 · Cited by 477
Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrián, F., Matzen, J. T., Anderson, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802982105 · Cited by 449
Yeoh, S., O'Donnell, R. A., Koussis, K., Dluzewski, A. R., Ansell, K. H., Osborne, S. A., Hackett, F., Withers-Martinez, C., Mitchell, G. H., Bannister, L. H., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.049 · Cited by 357
A Naturally Acquired Quotidian-Type Malaria in Man Transferable to Monkeys
Chin, W., Contacos, P. G., Coatney, G. R., & Kimball, H. R. (1965) · Science · doi:10.1126/science.149.3686.865 · Cited by 322
Luo, X., & Shen, C. (1987) · Medicinal Research Reviews · doi:10.1002/med.2610070103 · Cited by 320
Genomic-scale prioritization of drug targets: the TDR Targets database
Agüero, F., Al-Lazikani, B., Aslett, M., Berriman, M., Buckner, F. S., Campbell, R. K., Carmona, S., Carruthers, I. M., Chan, A. W. E., Chen, F., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2684 · Cited by 306
Mixed-species malaria infections in humans
Mayxay, M., Pukrittayakamee, S., Newton, P. N., & White, N. J. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.03.006 · Cited by 301
Gujjar, R., Marwaha, A., El Mazouni, F., White, J., White, K. L., Creason, S., Shackleford, D. M., Baldwin, J., Charman, W. N., Buckner, F. S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801343r · Cited by 251
Aponte, J. J., Schellenberg, D., Egan, A., Breckenridge, A., Carneiro, I., Critchley, J., Danquah, I., Dodoo, A., Kobbe, R., Lell, B., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61258-7 · Cited by 243
Self-citationGomes, M., Faiz, M., Gyapong, J., Warsame, M., Agbenyega, T., Babiker, A., Baiden, F., Yunus, E., Binka, F., Clerk, C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61734-1 · Cited by 219
Did They Really Say ... Eradication?
Roberts, L., & Enserink, M. (2007) · Science · doi:10.1126/science.318.5856.1544 · Cited by 215
Glucose-6-Phosphate Dehydrogenase Deficiency and Antimalarial Drug Development
Beutler, E., Duparc, S., & _, _. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.779 · Cited by 215
The Apicoplast: A Review of the Derived Plastid of Apicomplexan Parasites
(2005) · Current Issues in Molecular Biology · doi:10.21775/cimb.007.057 · Cited by 204
Baldwin, J., Michnoff, C. H., Malmquist, N. A., White, J., Roth, M. G., Rathod, P. K., & Phillips, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501100200 · Cited by 197
A Class of Potent Antimalarials and Their Specific Accumulation in Infected Erythrocytes
Wengelnik, K., Vidal, V., Ancelin, M. L., Cathiard, A.-M., Morgat, J. L., Kocken, C. H., Calas, M., Herrera, S., Thomas, A. W., & Vial, H. J. (2002) · Science · doi:10.1126/science.1067236 · Cited by 178
Kerr, I. D., Lee, J. H., Pandey, K. C., Harrison, A., Sajid, M., Rosenthal, P. J., & Brinen, L. S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013663 · Cited by 171
The Global Portfolio of New Antimalarial Medicines Under Development
Olliaro, P., & Wells, T. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.51 · Cited by 168
Self-citationVivax Malaria: A Major Cause of Morbidity in Early Infancy
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Hasanuddin, A., Warikar, N., Sugiarto, P., Tjitra, E., Anstey, N. M., & Price, R. N. (2009) · Clinical Infectious Diseases · doi:10.1086/599041 · Cited by 164
Selection of a trioxaquine as an antimalarial drug candidate
Cosledan, F., Fraisse, L., Pellet, A., Guillou, F., Mordmüller, B. G., Kremsner, P. G., Sabater, A. M., Mazier, D., Maffrand, J., & Meunier, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804338105 · Cited by 156
An Overview of Chemotherapeutic Targets for Antimalarial Drug Discovery
Olliaro, P., & Yuthavong, Y. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00036-9 · Cited by 150
Ohrt, C., Willingmyre, G. D., Lee, P. J., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2518-2524.2002 · Cited by 130
Protein kinases of malaria parasites: an update
Doerig, C., Billker, O., Haystead, T., Sharma, P., Tobin, A. B., & Waters, N. C. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.08.007 · Cited by 126
Grundner, C., Perrin, D., van Huijsduijnen, R. H., Swinnen, D., Gonzalez, J., Gee, C. L., Wells, T. N. C., & Alber, T. (2007) · Structure · doi:10.1016/j.str.2007.03.003 · Cited by 102
Self-citationGuinovart, C., Aponte, J. J., Sacarlal, J., Aíde, P., Leach, A. J., Bassat, Q., Macete, E., Dobaño, C., Lievens, M., Loucq, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005165 · Cited by 101
Self-citationHemmer, C. J., Holst, F. G. E., Kern, P., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01635.x · Cited by 100
Dunne, M. W., Singh, N., Shukla, M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429343 · Cited by 95
Patel, V., Mazitschek, R., Coleman, B. I., Nguyen, C., Urgaonkar, S., Cortese, J. F., Barker, R. H., Greenberg, E. F., Tang, W., Bradner, J. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801654y · Cited by 89
Nixon, G. L., Amewu, R. K., Sabbani, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701435h · Cited by 85
Plasmodium falciparum Purine Nucleoside Phosphorylase Is Critical for Viability of Malaria Parasites
Madrid, D. C., Ting, L.-M., Waller, K. L., Schramm, V. L., & Kim, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807218200 · Cited by 83
Cultivation of Plasmodium vivax
Udomsangpetch, R., Kaneko, O., Chotivanich, K., et al. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2007.09.010 · Cited by 80
Evidence-Based Annotation of the Malaria Parasite's Genome Using Comparative Expression Profiling
Zhou, Y., Ramachandran, V., Kumar, K. A., Westenberger, S. J., Refour, P., Zhou, B., Li, F., Young, J. A., Chen, K., Plouffe, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001570 · Cited by 80
Freundlich, J. S., Wang, F., Tsai, H.-C., Kuo, M. R., Shieh, H.-M., Anderson, J. W., Nkrumah, L. J., Valderramos, J., Yu, M., Kumar, T. R. S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701813200 · Cited by 76
Antimalarial drug resistance and the importance of drug quality monitoring.
Green, M. D. (2007) · PubMed · Cited by 20
Cited by
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
Chemical genetics of Plasmodium falciparum
Guiguemde, W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., et al. (2010) · Nature · doi:10.1038/nature09099 · Cited by 566
A transcriptional switch underlies commitment to sexual development in malaria parasites
Kafsack, B. F. C., Rovira-Graells, N., Clark, T. G., Bancells, C., Crowley, V. M., Campino, S. G., Williams, A. E., Drought, L. G., Kwiatkowski, D. P., Baker, D. A., et al. (2014) · Nature · doi:10.1038/nature12920 · Cited by 537
Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
Kingston, D. G. I. (2011) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 516
Metadata
- Authors
- Wells, T. N. C., Alonso, P. L., & Gutteridge, W. E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-10-16
- Volume
- 8
- Issue
- 11
- Pages
- 879-891
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2168950392
- Cited by
- 298
- References
- 45
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.